Age-associated neurodegenerative disorders such as Alzheimer's disease are a major
public health challenge, due to the demographic increase in the proportion of older …

Parkinson's disease (PD) is a chronic, progressive and disabling neurodegenerative
disorder. The prevalence of PD has risen considerably over the past decades. A growing …

Leucine-rich repeat kinase 2 (LRRK2) has been linked to several clinical disorders including
Parkinson's disease (PD), Crohn's disease and leprosy. Furthermore in rodents, LRRK2 …

Glyphosate-containing herbicides are among the most widely-used in the world. Although
glyphosate itself is relatively non-toxic, growing evidence suggests that commercial …

Although amyloid β (Aβ) and tau aggregates define the neuropathology of Alzheimer's
disease (AD), TDP-43 has recently emerged as a co-morbid pathology in more than half of …

The technologies related to ex vivo models and lab-on-a-chip devices for studying the
regeneration of brain, spinal cord, and peripheral nerve tissues are essential tools for neural …

Epidemiological analyses indicate that type 2 diabetes mellitus (T2DM) is a risk factor for
Alzheimer's disease (AD). They share common pathophysiological mechanisms. Thus, it has …

Despite Parkinson's Disease (PD) being the second most common neurodegenerative
disease, treatment options are limited. Consequently, there is an urgent need to identify and …

Spinal muscular atrophy (SMA) is the most common genetic disease affecting infants and
young adults. Due to mutation/deletion of the survival motor neuron (SMN) gene, SMA is …

Parkinson disease (PD) is the second most common neurodegenerative disorder and the
leading neurodegenerative cause of motor disability. Pathologic accumulation of …